EUSA Pharma has appointed Rolf Hoffmann to its Board of Directors. Rolf is currently chairman of Biotest AG, sits on the Board of Directors of Europe’s largest biotechnology company Genmab AG and is a director of San Francisco-based Trigemina. He brings to EUSA over 30 years’ international pharmaceutical experience having served in a number of senior roles in the industry, most recently 12 years with Amgen as senior vice president of commercial operations for the United States, and before that for SVP International and Europe.